comparemela.com

Bimmeda Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Triclabendazole Market to Cross US$ 632 1 Mn by 2031 with a Steady 4 1% CAGR, TMR Study

Efficacy of triclabendazole for treatment of liver fluke at various stages of the infection is augmenting triclabendazole market growthWilmington, Delaware, United States, July 19, 2023 (GLOBE NEWSWIRE) The global triclabendazole market stood at US$ 412.0 Mn in 2020 and is projected to grow at a CAGR of 4.1% during the forecast period from 2021 to 2031. Increase in incidence of liver fluke and efficacy of triclabendazole for treatment of the disease from the very early stage to mature stage a

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.